COMMUNIQUÉS West-GlobeNewswire
-
Texicare Selects CirrusMD to Provide Access to On-Demand Virtual Care for Small Employer Groups in Texas
30/07/2024 - 16:00 -
Acentra Health Honored as an AWS Champion for Digital Transformation in the Public Health Sector
30/07/2024 - 15:30 -
Marius Pharmaceuticals Submits KYZATREX® (Testosterone Undecanoate) CIII Capsules for Approval to Health Canada
30/07/2024 - 15:30 -
Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates
30/07/2024 - 15:15 -
Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2024
30/07/2024 - 15:10 -
Arch Biopartners Arranges Non-Brokered Private Placement
29/07/2024 - 22:52 -
Earth Science Tech, Inc., Reports its June 30, 2024, Quarter Results, Recording Over $8.5M in Revenue and $1.07M in Net Profit
29/07/2024 - 22:48 -
Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
29/07/2024 - 22:30 -
Bionomics to Provide a Corporate Update and Discuss End-of-Phase 2 Meeting Outcomes on the Development of BNC210 in PTSD on July 31, 2024
29/07/2024 - 22:30 -
Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024
29/07/2024 - 22:30 -
Nyxoah Publiera ses Résultats Financiers pour le Deuxième Trimestre Et le Premier Semestre 2024 le 6 Août 2024
29/07/2024 - 22:30 -
Tilray Brands Reports Record Financial Results, Achieves 26% Net Revenue Growth
29/07/2024 - 22:05 -
Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024
29/07/2024 - 22:05 -
CVRx Reports Second Quarter 2024 Financial and Operating Results
29/07/2024 - 22:05 -
Terns Pharmaceuticals Appoints Biotech Executive Elona Kogan as Chief Legal Officer and Announces Upcoming CFO Transition
29/07/2024 - 22:05 -
Rani Therapeutics to Participate in August Investor Conferences
29/07/2024 - 22:05 -
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results
29/07/2024 - 22:05 -
IMUNON to Report Topline Results from the Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer Tomorrow
29/07/2024 - 22:05 -
Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in China
29/07/2024 - 22:05
Pages